RxDoctor Payments Data

Karin Evan, MD

Otolaryngology · Minneapolis, MNNPI 1508867003

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,181 of the $1,727 with a category attached, or 68.4%. 14 manufacturers reported payments, led by Medical Device Business Services, Inc. at 31.6% of the total. Reporting peaked in 2019 at $782 and has fallen 85.1% since, to $116 in 2025.

$1,727in general payments, 2019–2025

Across 48 payments — averaging $35.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$545
  • Stryker$340
  • Aerin Medical Inc.$175
  • GSK$162
  • Acclarent, Inc$117
  • Optinose US, Inc.$78
  • plus $308 from 8 others

What the payments were for

  • Travel & lodging$54532%
  • Food & beverage$1,18168%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,727 in reported general payments places this provider in the 70th percentile of 181 otolaryngology providers in Minnesota.

See all otolaryngology providers in Minnesota

Medicare billing

Part B allowed, 2024
$59,903
Medicare patients
292
Services billed
603

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide190$12,727
Fluticasone Propionate148$3,558
Azelastine Hcl47$1,886
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth15$1,832
Ofloxacin34$744
Cefdinir31$693
Omeprazole22$569
Betamethasone Dipropionate15$456
Doxycycline Monohydrate31$365
Famotidine19$237
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav21$205
Prednisone81$173
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim21$114

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →